STOCKS | Lukang Biochemical Says Operations Normal After Share Price Moves Trigger Volatility Notice

Lukang Biochemical said its current production and business operations are normal and have not seen any major changes after its shares met the criteria for abnormal trading fluctuations. According to Jin10, the company issued a volatility announcement stating that over three consecutive trading days—July 1, 2026, July 2, 2026, and July 3, 2026—the cumulative deviation in its closing price increase reached 20.66%. Under relevant provisions of the Shenzhen Stock Exchange Trading Rules, this falls under abnormal stock trading fluctuations. The company said it has noticed that market attention has recently increased for sectors related to livestock and poultry breeding and the veterinary drug industry chain, with trading activity in those sectors rising. Lukang Biochemical said its main business covers the research and development, production, and sales of animal health products, plant protection products, and food additives. It reiterated that its current production and operating conditions are normal and that no major changes have occurred.